Immuron IMRN
NASDAQ IMRN
$1.25 +0.01 (+1.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Immuron (IMRN) Cash & Current Investments (2015 - 2026)

Immuron (IMRN) posted Cash & Current Investments of $9.0 million for Q3 2026, up 218.59% on a QoQ basis from $2.8 million in Q4 2025, and up 31759.15% year-over-year from N/an in Q3 2025.

Analysis

Immuron (IMRN) Cash & Current Investments (2015 - 2026) Analysis & Trends

Immuron has reported Cash & Current Investments for 12 years, with the latest figure at $9.0 million in Q3 2026.

  • On a quarterly basis, Cash & Current Investments rose 31759.15% year-over-year to $9.0 million in Q3 2026; TTM through Aug 2026 was $9.0 million, a 31759.15% increase from a year earlier, with the FY2026 full-year figure at $9.0 million, up 31759.15% from the prior year.
  • Cash & Current Investments was $9.0 million for Q3 2026 at Immuron, up from $2.8 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $15.8 million in Q2 2022, with the low at $28305.3 in Q3 2025.
  • Average Cash & Current Investments over 5 years is $8.0 million, with a median of $8.4 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2026: Cash & Current Investments sank 98.76% in 2023, then jumped 31759.15% in 2026.
  • Over 5 years, Cash & Current Investments stood at $14.5 million in 2022, then declined by 14.91% to $12.4 million in 2023, then sank by 38.35% to $7.6 million in 2024, then slumped by 62.87% to $2.8 million in 2025, then soared by 218.59% to $9.0 million in 2026.
  • The last three Cash & Current Investments figures came in at $9.0 million (Q3 2026), $2.8 million (Q4 2025), and $28305.3 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Amgen 212.54 Bn 198.55 Bn 7.24 Bn 13.99 Bn
2 Gilead Sciences 186.84 Bn 183.58 Bn 6.22 Bn 3.18 Bn
3 Vertex Pharmaceuticals 129.39 Bn 121.54 Bn 2.84 Bn 7.85 Bn
4 Regeneron Pharmaceuticals 82.05 Bn 74.06 Bn 3.93 Bn 7.99 Bn
5 Moderna 69.00 Bn 63.87 Bn 52.00 Mn 5.14 Bn
6 Argenx Se 61.15 Bn 55.97 Bn 1.37 Bn 5.18 Bn
7 Alnylam Pharmaceuticals 32.67 Bn 29.37 Bn 992.69 Mn 3.31 Bn
8 Biogen 32.37 Bn 31.08 Bn 1.96 Bn 1.29 Bn
9 Roivant Sciences 28.18 Bn 28.87 Bn 1.16 Mn -
10 Immuron 7.25 Mn -1.77 Mn - 9.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 28, 2026 9.02 Mn
Dec 31, 2025 2.83 Mn
Sep 2, 2025 28,305.26
Jun 30, 2025 1.81 Mn
Dec 31, 2024 7.62 Mn
Sep 9, 2024 77,676.77
Jun 30, 2024 7.68 Mn
Dec 31, 2023 12.36 Mn
Sep 28, 2023 12.45 Mn
Aug 30, 2023 189,937.98
Jun 30, 2023 12.69 Mn
Dec 31, 2022 14.53 Mn
Aug 31, 2022 15.38 Mn
Jun 30, 2022 15.84 Mn
Dec 31, 2021 18.34 Mn
Sep 30, 2021 18.42 Mn
Jun 30, 2021 19.29 Mn
Dec 31, 2020 2.38 Mn
Sep 1, 2020 3.25 Mn
Jun 30, 2020 2.13 Mn
API Access

Immuron Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IMRN&period=max&api_key=YOUR_API_KEY